{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T23:49:24Z","timestamp":1695944964660},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9599-17","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T17:15:51Z","timestamp":1514308551000},"page":"1145-1149","source":"Crossref","is-referenced-by-count":3,"title":["Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin Type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis"],"prefix":"10.2169","volume":"57","author":[{"given":"Masuho","family":"Saburi","sequence":"first","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"},{"name":"Department of Hematology, Oita Kouseiren Tsurumi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nashimoto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Moroga","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniko","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"},{"name":"Department of Hematology, Oita Kouseiren Tsurumi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Daa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Shirao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tokuhira M, Watanabe R, Nemoto T, et al. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53: 616-623, 2012.","DOI":"10.3109\/10428194.2011.625101"},{"key":"2","unstructured":"2. Loo EY, Medeiros LJ, Aladily TN, et al. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol 37: 1290-1297, 2013."},{"key":"3","unstructured":"3. Carbone A, Spina M, Gloghini A, Tirelli U. Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome. Am J Hematol 86: 170-179, 2011."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tokuhira M, Tabayashi T, Tanaka Y, et al. The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis. J Clin Exp Hematop 56: 165-169, 2017.","DOI":"10.3960\/jslrt.56.165"},{"key":"5","unstructured":"5. Andersson J. Epstein-Barr virus and Hodgkin's lymphoma. Herpes 13: 12-16, 2006."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Murata T, Sato Y, Kimura H. Modes of infection and oncogenesis by the Epstein-Barr virus. Rev Med Virol 24: 242-253, 2014.","DOI":"10.1002\/rmv.1786"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Murata T, Tsurumi T. Switching of EBV cycles between latent and lytic states. Rev Med Virol 24: 142-153, 2014.","DOI":"10.1002\/rmv.1780"},{"key":"8","unstructured":"8. Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Transpl Infect Dis 18: 423-430, 2016."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Leaver S, Amlot P, Thuraisingham R, Norton A, Aitken C, Cavenagh JD. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient. Clin Lab Haematol 26: 351-353, 2004.","DOI":"10.1111\/j.1365-2257.2004.00626.x"},{"key":"10","unstructured":"10. Schachtner T, Reinke P. Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study. Transpl Infect Dis 18: 881-888, 2016."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/8\/57_9599-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T14:30:32Z","timestamp":1570545032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/8\/57_9599-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9599-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}